More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.
Publication
, Journal Article
Walter, EB; Talaat, KR; Gurtman, A
Published in: N Engl J Med
March 24, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
March 24, 2022
Volume
386
Issue
12
Start / End Page
1192 / 1193
Location
United States
Related Subject Headings
- Vaccination
- SARS-CoV-2
- Humans
- General & Internal Medicine
- Child
- COVID-19 Vaccines
- COVID-19
- BNT162 Vaccine
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Walter, E. B., Talaat, K. R., & Gurtman, A. (2022). More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply. N Engl J Med, 386(12), 1192–1193. https://doi.org/10.1056/NEJMc2201556
Walter, Emmanuel B., Kawsar R. Talaat, and Alejandra Gurtman. “More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.” N Engl J Med 386, no. 12 (March 24, 2022): 1192–93. https://doi.org/10.1056/NEJMc2201556.
Walter EB, Talaat KR, Gurtman A. More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply. N Engl J Med. 2022 Mar 24;386(12):1192–3.
Walter, Emmanuel B., et al. “More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply.” N Engl J Med, vol. 386, no. 12, Mar. 2022, pp. 1192–93. Pubmed, doi:10.1056/NEJMc2201556.
Walter EB, Talaat KR, Gurtman A. More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. Reply. N Engl J Med. 2022 Mar 24;386(12):1192–1193.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
March 24, 2022
Volume
386
Issue
12
Start / End Page
1192 / 1193
Location
United States
Related Subject Headings
- Vaccination
- SARS-CoV-2
- Humans
- General & Internal Medicine
- Child
- COVID-19 Vaccines
- COVID-19
- BNT162 Vaccine
- 42 Health sciences
- 32 Biomedical and clinical sciences